EUVIMEDEUVIMED entdecken
Crossref

Bairui granules attenuate ulcerative colitis via microbial-metabolite crosstalk and Isorhamnetin-3-O-glucoside-mediated JAK2/STAT3 suppression

Fang Zhang, Haonan Xu, Ke Che, Yu Cui, Qisheng Yao, Tingting Sun, Yan Che, Hao Chen

Phytomedicine · 2025-11 · 148 · 157388

DOI: 10.1016/j.phymed.2025.157388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Fang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; School of Food Engineering, Anhui Science and T…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Janus Kinase 2, STAT3 Transcription Factor, Drugs, Chinese Herbal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Anhui Provincial Key Research and Development Plan, Anhui Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUD: Bairui Granules (BRKL), a standardized botanical drug derived from Thesium chinense Turcz., has been clinically used for respiratory infections. However, its potential in ulcerative colitis (UC) and underlying mechanisms remain unexplored. This study elucidated the therapeutic effects and mechanisms of BRKL against UC through integrated phytochemistry, multi-omics, and pharmacological approaches. METHODS: We investigated the protective effects of BRKL on DSS-induced colitis in mice. Pathological characteristics and oxidative stress of the distal colon were assessed. The impact of BRKL on gut microbiota was analyzed using 16S rRNA sequencing, while metabolomics explored changes in small molecular metabolites. UPLC-QE-MS validated BRKL's prototype compounds in the bloodstream, and network pharmacology predicted its targets and pathways. Molecular docking/dynamics validated target engaagement, followed by experimental validation in vitro and in vivo. RESULTS: BRKL significantly alleviated colitis symptoms, restored gut barrier integrity, and reduced oxidative stress. It reshaped gut microbiota composition (Akkermansia, Lachnospiraceae; Escherichia-Shigella) and modulated 22 colon metabolites linked to histidine and JAK-STAT pathways. Network pharmacology identified JAK2 as a core target, corroborated by molecular dynamics showing stable binding of BRKL-derived Withalongolide L to JAK2. BRKL and its active component Isorhamnetin-3-O-glucoside (0.1 mg/g crude drug) suppressed IL-6/JAK2/STAT3 phosphorylation, reduced apoptosis, and inhibited pro-inflammatory cytokines . Structural analysis confirmed Isorhamnetin-3-O-glucoside as a novel JAK2 inhibitor scaffold (Tanimoto index

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeJanus Kinase 2STAT3 Transcription FactorDrugs, Chinese HerbalQuercetinAnimalsGastrointestinal MicrobiomeMiceMaleMice, Inbred C57BLMolecular Docking SimulationOxidative StressGlucosidesSignal TransductionDisease Models, AnimalColon

Stichwörter der Autor:innen

Bairui GranulesGut MicrobiotaIL6/JAK2/STAT3 PathwayIsorhamnetin-3-O-glucosideMetabolomicsUlcerative Colitis

Substanzen

Janus Kinase 2STAT3 Transcription FactorJak2 protein, mouseDrugs, Chinese HerbalStat3 protein, mouseQuercetin3-methylquercetinGlucosides

Autor:innen und Institutionen

  • College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; School of Food Engineering, Anhui Science and Technology University, Fengyang 233100, China.
  • College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; College of Animal Science, Anhui Science and Technology University, Fengyang 233100, China.
  • School of Food Engineering, Anhui Science and Technology University, Fengyang 233100, China.
  • College of Animal Science, Anhui Science and Technology University, Fengyang 233100, China.
  • Planting Department, Jiuhua Huayuan Pharmaceutical Co., Ltd., Chuzhou 239000, China.
  • College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230000, China; Planting Department, Jiuhua Huayuan Ph…

Förderung

  • Anhui Provincial Key Research and Development Plan
  • Anhui Provincial Natural Science Foundation

Zitieren

APA

Zhang, F., Xu, H., Che, K., Cui, Y., Yao, Q., Sun, T., Che, Y., & Chen, H. (2025). Bairui granules attenuate ulcerative colitis via microbial-metabolite crosstalk and Isorhamnetin-3-O-glucoside-mediated JAK2/STAT3 suppression. Phytomedicine, 148, 157388. https://doi.org/10.1016/j.phymed.2025.157388

Vancouver

Zhang F, Xu H, Che K, Cui Y, Yao Q, Sun T, et al. Bairui granules attenuate ulcerative colitis via microbial-metabolite crosstalk and Isorhamnetin-3-O-glucoside-mediated JAK2/STAT3 suppression. Phytomedicine. 2025;148:157388. doi:10.1016/j.phymed.2025.157388

BibTeX
@article{Zhang2025,
  author = {Zhang, Fang and Xu, Haonan and Che, Ke and Cui, Yu and Yao, Qisheng and Sun, Tingting and Che, Yan and Chen, Hao},
  title = {Bairui granules attenuate ulcerative colitis via microbial-metabolite crosstalk and Isorhamnetin-3-O-glucoside-mediated JAK2/STAT3 suppression},
  journal = {Phytomedicine},
  year = {2025},
  volume = {148},
  pages = {157388},
  doi = {10.1016/j.phymed.2025.157388}
}
Kostenlos starten →